Insider Trading Activity Integra LifeSciences Holdings Corporation (NASDAQ:IART) – Director Bought 2,500 shares of Stock

ME Staff
-
0

Insider Trading Activity For Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Donald E Morel Jr , Director of Integra LifeSciences Holdings Corporation (NASDAQ:IART) reportedly Bought 2,500 shares of the company’s stock at an average price of 49.29 for a total transaction amount of $123,225.00 SEC Form

Insider Trading History For Integra LifeSciences Holdings Corporation (NASDAQ:IART)

  • On 5/31/2013 Jerry E Corbin, VP, sold 1,876 with an average share price of $38.07 per share and the total transaction amounting to $71,419.32.View SEC Filing
  • On 7/30/2013 Judith Ogrady, VP, sold 2,000 with an average share price of $38.50 per share and the total transaction amounting to $77,000.00.View SEC Filing
  • On 8/1/2013 Judith Ogrady, VP, sold 1,000 with an average share price of $39.50 per share and the total transaction amounting to $39,500.00.View SEC Filing
  • On 8/19/2013 John Henneman III, CFO, sold 30,000 with an average share price of $42.08 per share and the total transaction amounting to $1,262,400.00.View SEC Filing
  • On 8/19/2013 Brian Larkin, VP, sold 7,490 with an average share price of $41.90 per share and the total transaction amounting to $313,831.00.View SEC Filing
  • On 8/23/2013 Deborah Leonetti, VP, sold 8,906 with an average share price of $41.68 per share and the total transaction amounting to $371,202.08.View SEC Filing
  • On 8/30/2013 Richard Gorelick, VP, sold 3,000 with an average share price of $40.79 per share and the total transaction amounting to $122,370.00.View SEC Filing

    • Analyst Ratings For Integra LifeSciences Holdings Corporation (NASDAQ:IART)
    These are 2 Hold Ratings, 8 Buy Ratings .
    The current consensus rating for Integra LifeSciences Holdings Corporation (NASDAQ:IART) is Buy (Score: 2.80) with a consensus target price of $52.35 , a potential (6.66% upside)

    Analyst Ratings History For Integra LifeSciences Holdings Corporation (NASDAQ:IART)

    • On 9/21/2015 Bank of America Corporation Upgraded rating Neutral to Buy with a price target of $36.00 to $39.50
    • On 11/12/2015 Citigroup Inc. Initiated Coverage of rating Buy with a price target of $37.50
    • On 7/13/2016 J P Morgan Chase & Co Initiated Coverage of rating Overweight
    • On 9/23/2016 Argus Boost Price Target of rating Buy with a price target of $45.00 to $52.50
    • On 10/28/2016 Lake Street Capital Upgraded rating Hold to Buy with a price target of $46.00
    • On 1/6/2017 JMP Securities Upgraded rating Market Perform to Outperform with a price target of $50.00
    • On 1/13/2017 Barclays PLC Reiterated Rating Equal Weight with a price target of $84.00 to $42.00

    Recent Trading Activity for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
    Shares of Integra LifeSciences Holdings Corporation closed the previous trading session at 49.08 up +0.17 0.35% with 324,548 shares trading hands.